Bedikian, Agop Y <br/><br/>
Pharmacokinetics and safety of Marqibo (vincristine sulfate liposomes injection) in cancer patients with impaired liver function.  [electronic resource] 

 -  Journal of clinical pharmacology  Aug 2011 
 - 1205-12 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1552-4604 
<br/><br/><label>Standard No.: </label>10.1177/0091270010381499  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Agents, Phytogenic--administration & dosage<br/>Ascites--physiopathology<br/>Female<br/>Half-Life<br/>Hepatic Insufficiency--etiology<br/>Humans<br/>Liposomes<br/>Liver Neoplasms--drug therapy<br/>Male<br/>Melanoma--blood<br/>Metabolic Clearance Rate<br/>Middle Aged<br/>Neoplasm Staging<br/>Pharmaceutical Vehicles--therapeutic use<br/>Skin Neoplasms--blood<br/>Survival Analysis<br/>Tubulin Modulators--administration & dosage<br/>Uveal Neoplasms--blood<br/>Vincristine--administration & dosage